Company information:
Cybele Therapeutics Ltd (No: 12172386)
Address: 71 KINGSWAY, LONDON, WC2B 6ST, ENGLAND
Status: Active - Proposal to Strike off
Incorporated: 23-Aug-2019
Accounts Next Due: 30-Sep-2022
Next Confirmation Statement Due: 12-Dec-2022
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: HOUMAN ASHRAFIAN ( DOB: Feb-1975 From: Dec-2019 )
Current Director: HOUMAN ASHRAFIAN ( DOB: Feb-1975 From: Dec-2019 )
Current Director: SORAYA BEKKALI ( DOB: Mar-1972 From: Dec-2019 )
Current Director: CATHERINE ELIZABETH BINGHAM ( DOB: Oct-1965 From: Dec-2019 )
Current Director: JONATHON ALAN DINES ( DOB: Aug-1982 From: Aug-2019 )
Resigned Director: JAMES ALLISTER JOHN COSTINE ( DOB: May-1982 From: Aug-2019 To: Dec-2019 )
Resigned Director: JONATHON ALAN DINES ( DOB: Aug-1982 From: Aug-2019 To: Dec-2019 )
Persons of Significant Control:
Sv7 (Imf) Gp Llp, 71 Kingsway, London, WC2B 6ST, United Kingdom: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2019-08-23)
Company Accounts Summary (£)
Item | 2020-12-31 | Chart |
---|---|---|
Fixed assets | 0.0 | |
Fixed assets / Intangible assets | 0.0 | |
Fixed assets / Property, plant and equipment | 0.0 | |
Fixed assets / Investments, fixed assets | 0.0 | |
Current assets | 20,013 | 20013.0 |
Current assets / Total inventories | 0.0 | |
Current assets / Debtors | 42 | 42.0 |
Current assets / Debtors / Trade debtors / trade receivables | 42 | 42.0 |
Current assets / Debtors / Prepayments and accrued income | 0.0 | |
Current assets / Current asset investments | 0.0 | |
Current assets / Cash at bank and on hand | 19,971 | 19971.0 |
Prepayments and accrued income, not expressed within current asset subtotal | 0.0 | |
Net current assets (liabilities) | 19,850 | 19850.0 |
Total assets less current liabilities | 19,850 | 19850.0 |
Provisions for liabilities, balance sheet subtotal | 0.0 | |
Accrued liabilities, not expressed within creditors subtotal | 0.0 | |
Net assets (liabilities) | -321,301 | -321301.0 |
Equity / share capital and reserves | 321,301 | 321301.0 |